Company news

TheraCryf PLC news in 2024

TheraCryf PLC's news releases, calls and decks from 2024, newest first.

View company

Half-year Report

November 28, 2024

European Patent Office award decision

November 27, 2024

Issue of Equity and Total Voting Rights

November 14, 2024

Publication of peer reviewed data

November 11, 2024

Passing of Dr Sue Foden, Chair

November 4, 2024

Grant of Options and PDMR Dealings

August 29, 2024

Publication of peer-reviewed data on SFX-01

July 10, 2024

Annual Financial Report and Notice of AGM

June 21, 2024

TheraCryf Research and Development Day

June 13, 2024

Final Results - Correction

May 28, 2024

Notice of R&D presentation

May 22, 2024

Chronos Integration Update

May 2, 2024

Change of Name

April 25, 2024

Result of Retail Offer

April 4, 2024

Retail Offer

March 19, 2024

SFX-01 positive update in bowel cancer models

February 27, 2024

Positive update on SFX-01 in vitro GBM studies

February 19, 2024

Notice of Dispute lodged with Stalicla SA

February 9, 2024

Series B Fund Raise by partner, Stalicla SA

January 16, 2024

Calls in 2024

Decks in 2024